Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| AbbVie Inc.ABBV · Entity 2800 | Director | May 08, 2026 | May 12, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
AbbVie Inc.
Report date May 08, 2026 · Filed May 12, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common Stock, $0.01 par valueSEC Table I · non-derivative | Direct | 28,076 |
Reported balance
After 2026-05-08 transaction · row 1
1 source rowRow 1 · 2026-05-08 · Grant · Acquired 1,118 · Balance 28,076 F1: These are restricted stock units awarded under the AbbVie Amended and Restated 2013 Incentive Stock Program (the "Program"). They will be paid, on a one-to-one basis, in shares of AbbVie common stock on the earlier of the date of the director's separation from service, death, or the occurrence of a change in control (as defined in the Program). |
Filing footnotes · ownership attribution and instrument terms
F1: These are restricted stock units awarded under the AbbVie Amended and Restated 2013 Incentive Stock Program (the "Program"). They will be paid, on a one-to-one basis, in shares of AbbVie common stock on the earlier of the date of the director's separation from service, death, or the occurrence of a change in control (as defined in the Program).
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| May 08, 2026 Filed May 12, 2026 21:00 UTC | AbbVie Inc. ABBV · Entity 2800 | GrantCommon Stock, $0.01 par value | 1,118 | $0.00 | $0.00 |
DisclosureSEC source: 0001563579-26-000002 · form4-05122026_050505.xml · nonDerivative · entry 1 BURNSIDE WILLIAM H.L. · CIK 0001563579 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 28,076 F1 · shares: These are restricted stock units awarded under the AbbVie Amended and Restated 2013 Incentive Stock Program (the "Program"). They will be paid, on a one-to-one basis, in shares of AbbVie common stock on the earlier of the date of the director's separation from service, death, or the occurrence of a change in control (as defined in the Program). Read SEC document |
| May 09, 2025 Filed May 13, 2025 21:05 UTC | AbbVie Inc. ABBV · Entity 2800 | GrantCommon Stock, $0.01 par value | 1,203 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-25-012795 · form4-05132025_050507.xml · nonDerivative · entry 1 BURNSIDE WILLIAM H.L. · CIK 0001563579 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 26,958 F1 · shares: These are restricted stock units awarded under the AbbVie Amended and Restated 2013 Incentive Stock Program (the "Program"). They will be paid, on a one-to-one basis, in shares of AbbVie common stock on the earlier of the date of the director's separation from service, death, or the occurrence of a change in control (as defined in the Program). Read SEC document |
| May 03, 2024 Filed May 7, 2024 22:30 UTC | AbbVie Inc. ABBV · Entity 2800 | GrantCommon Stock, $0.01 par value | 1,322 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-24-012525 · form4-05072024_060517.xml · nonDerivative · entry 1 BURNSIDE WILLIAM H.L. · CIK 0001563579 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 25,755 F1 · shares: These are restricted stock units awarded under the AbbVie Amended and Restated 2013 Incentive Stock Program (the "Program"). They will be paid, on a one-to-one basis, in shares of AbbVie common stock on the earlier of the date of the director's separation from service, death, or the occurrence of a change in control (as defined in the Program). Read SEC document |
| May 05, 2023 Filed May 9, 2023 21:00 UTC | AbbVie Inc. ABBV · Entity 2800 | GrantCommon Stock, $0.01 par value | 1,450 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-23-007665 · form4-05092023_050504.xml · nonDerivative · entry 1 BURNSIDE WILLIAM H.L. · CIK 0001563579 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 24,433 F1 · shares: These are restricted stock units awarded under the AbbVie Amended and Restated 2013 Incentive Stock Program (the "Program"). They will be paid, on a one-to-one basis, in shares of AbbVie common stock on the earlier of the date of the director's separation from service, death, or the occurrence of a change in control (as defined in the Program). Read SEC document |
| May 06, 2022 Filed May 9, 2022 21:10 UTC | AbbVie Inc. ABBV · Entity 2800 | GrantCommon Stock, $0.01 par value | 1,421 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-22-002926 · edgar.xml · nonDerivative · entry 1 BURNSIDE WILLIAM H.L. · CIK 0001563579 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,983 F1 · shares: These are restricted stock units awarded under the AbbVie Amended and Restated 2013 Incentive Stock Program (the "Program"). They will be paid, on a one-to-one basis, in shares of AbbVie common stock on the earlier of the date of the director's separation from service, death, or the occurrence of a change in control (as defined in the Program). Read SEC document |
| May 07, 2021 Filed May 11, 2021 21:05 UTC | AbbVie Inc. ABBV · Entity 2800 | GrantCommon Stock, $0.01 par value | 1,681 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-21-005200 · edgar.xml · nonDerivative · entry 1 BURNSIDE WILLIAM H.L. · CIK 0001563579 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,562 F1 · shares: These are restricted stock units awarded under the AbbVie 2013 Incentive Stock Program (the "Program"). They will be paid, on a one-to-one basis, in shares of AbbVie common stock on the earlier of the date of the director's separation from service, death, or the occurrence of a change in control (as defined in the Program). Read SEC document |
| May 08, 2020 Filed May 12, 2020 20:58 UTC | AbbVie Inc. ABBV · Entity 2800 | GrantCommon Stock, $0.01 par value | 2,333 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-20-005778 · edgar.xml · nonDerivative · entry 1 BURNSIDE WILLIAM H.L. · CIK 0001563579 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,881 F1 · kind: These are restricted stock units awarded under the AbbVie 2013 Incentive Stock Program (the "Program"). They will be paid, on a one-to-one basis, in shares of AbbVie common stock on the earlier of the date of the director's separation from service, death, or the occurrence of a change in control (as defined in the Program). F1 · price: These are restricted stock units awarded under the AbbVie 2013 Incentive Stock Program (the "Program"). They will be paid, on a one-to-one basis, in shares of AbbVie common stock on the earlier of the date of the director's separation from service, death, or the occurrence of a change in control (as defined in the Program). Read SEC document |
| May 03, 2019 Filed May 7, 2019 20:52 UTC | AbbVie Inc. ABBV · Entity 2800 | GrantCommon Stock, $0.01 par value | 2,419 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-19-005668 · edgar.xml · nonDerivative · entry 1 BURNSIDE WILLIAM H.L. · CIK 0001563579 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,548 F1 · kind: These are restricted stock units awarded under the AbbVie 2013 Incentive Stock Program (the "Program"). They will be paid, on a one-to-one basis, in shares of AbbVie common stock on the earlier of the date of the director's separation from service, death, or the occurrence of a change in control (as defined in the Program). F1 · price: These are restricted stock units awarded under the AbbVie 2013 Incentive Stock Program (the "Program"). They will be paid, on a one-to-one basis, in shares of AbbVie common stock on the earlier of the date of the director's separation from service, death, or the occurrence of a change in control (as defined in the Program). Read SEC document |
| May 04, 2018 Filed May 8, 2018 00:26 UTC | AbbVie Inc. ABBV · Entity 2800 | GrantCommon stock, $0.01 par value | 1,899 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-18-006405 · edgar.xml · nonDerivative · entry 1 BURNSIDE WILLIAM H.L. · CIK 0001563579 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,129 F1 · kind: These are restricted stock units awarded under the AbbVie 2013 Incentive Stock Program (the "Program"). They will be paid, on a one-to-one basis, in shares of AbbVie common stock on the earlier of the date of the director's separation from service, death, or the occurrence of a change in control (as defined in the Program). F1 · price: These are restricted stock units awarded under the AbbVie 2013 Incentive Stock Program (the "Program"). They will be paid, on a one-to-one basis, in shares of AbbVie common stock on the earlier of the date of the director's separation from service, death, or the occurrence of a change in control (as defined in the Program). Read SEC document |
| May 05, 2017 Filed May 9, 2017 21:12 UTC | AbbVie Inc. ABBV · Entity 2800 | GrantCommon stock, $0.01 par value | 2,770 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-17-006921 · edgar.xml · nonDerivative · entry 1 BURNSIDE WILLIAM H.L. · CIK 0001563579 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,230 F1 · kind: These are restricted stock units awarded under the AbbVie 2013 Incentive Stock Program (the "Program"). They will be paid, on a one-to-one basis, in shares of AbbVie common stock on the earlier of the date of the director's separation from service, death, or the occurrence of a change in control (as defined in the Program). F1 · price: These are restricted stock units awarded under the AbbVie 2013 Incentive Stock Program (the "Program"). They will be paid, on a one-to-one basis, in shares of AbbVie common stock on the earlier of the date of the director's separation from service, death, or the occurrence of a change in control (as defined in the Program). Read SEC document |
| May 06, 2016 Filed May 10, 2016 21:19 UTC | AbbVie Inc. ABBV · Entity 2800 | GrantCommon stock, $0.01 par value | 2,974 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-16-024265 · edgar.xml · nonDerivative · entry 1 BURNSIDE WILLIAM H.L. · CIK 0001563579 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,460 F1 · kind: These are restricted stock units awarded under the AbbVie 2013 Incentive Stock Program (the "Program"). They will be paid, on a one-to-one basis, in shares of AbbVie common stock on the earlier of the date of the director's separation from service, death, or the occurrence of a change in control (as defined in the Program). F1 · price: These are restricted stock units awarded under the AbbVie 2013 Incentive Stock Program (the "Program"). They will be paid, on a one-to-one basis, in shares of AbbVie common stock on the earlier of the date of the director's separation from service, death, or the occurrence of a change in control (as defined in the Program). Read SEC document |
| May 08, 2015 Filed May 12, 2015 21:52 UTC | AbbVie Inc. ABBV · Entity 2800 | GrantCommon stock, $0.01 par value | 2,187 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-15-007668 · edgar.xml · nonDerivative · entry 1 BURNSIDE WILLIAM H.L. · CIK 0001563579 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,486 F1 · kind: These are restricted stock units awarded under the AbbVie 2013 Incentive Stock Program (the "Program"). They will be paid, on a one-to-one basis, in shares of AbbVie common stock on the earlier of the date of the director's separation from service, death, or the occurrence of a change in control (as defined in the Program). F1 · price: These are restricted stock units awarded under the AbbVie 2013 Incentive Stock Program (the "Program"). They will be paid, on a one-to-one basis, in shares of AbbVie common stock on the earlier of the date of the director's separation from service, death, or the occurrence of a change in control (as defined in the Program). Read SEC document |
| May 09, 2014 Filed May 13, 2014 21:20 UTC | AbbVie Inc. ABBV · Entity 2800 | GrantCommon stock, $0.01 par value | 2,764 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-14-008316 · edgar.xml · nonDerivative · entry 1 BURNSIDE WILLIAM H.L. · CIK 0001563579 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,299 F1 · kind: These are restricted stock units awarded under the AbbVie 2013 Incentive Stock Program (the "Program"). They will be paid, on a one-to-one basis, in shares of AbbVie common stock on the earlier of the date of the director's separation from service, death, or the occurrence of a change in control (as defined in the Program). F1 · price: These are restricted stock units awarded under the AbbVie 2013 Incentive Stock Program (the "Program"). They will be paid, on a one-to-one basis, in shares of AbbVie common stock on the earlier of the date of the director's separation from service, death, or the occurrence of a change in control (as defined in the Program). Read SEC document |
| May 06, 2013 Filed May 8, 2013 21:09 UTC | AbbVie Inc. ABBV · Entity 2800 | GrantCommon stock, $0.01 par value | 2,535 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-13-008009 · edgar.xml · nonDerivative · entry 1 BURNSIDE WILLIAM H.L. · CIK 0001563579 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,535 F1 · kind: These are restricted stock units awarded under the AbbVie 2013 Incentive Stock Program (the "Program"). They will be paid, on a one-to-one basis, in shares of AbbVie common stock on the earlier of the date of the director's separation from service, death, or the occurrence of a change in control (as defined in the Program). F1 · price: These are restricted stock units awarded under the AbbVie 2013 Incentive Stock Program (the "Program"). They will be paid, on a one-to-one basis, in shares of AbbVie common stock on the earlier of the date of the director's separation from service, death, or the occurrence of a change in control (as defined in the Program). Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.